WU
32
2
IR
66
3
IPG
56
3
ILMN
42
5
TSCO
49
5
FDX
43
3
ADBE
49
3
ACN
52
3
MRK
25
-2
XRX
44
3
LNC
39
3
PGR
65
2
EXC
53
-3
MAT
46
12
WY
54
4
BMY
60
2
VZ
50
3
GPC
40
3
BAC
53
3
PPL
54
-5
WU
32
2
IR
66
3
IPG
56
3
ILMN
42
5
TSCO
49
5
FDX
43
3
ADBE
49
3
ACN
52
3
MRK
25
-2
XRX
44
3
LNC
39
3
PGR
65
2
EXC
53
-3
MAT
46
12
WY
54
4
BMY
60
2
VZ
50
3
GPC
40
3
BAC
53
3
PPL
54
-5
Financhill
Back

Recursion Pharmaceuticals Vs. Revance Therapeutics Industry Stock Comparison

Sell
44

RXRX
Recursion Pharmaceuticals

Last Price:
5.70
Seasonality Move:
6.36%
Sell
9

RVNC
Revance Therapeutics

Last Price:
3.73
Seasonality Move:
6.97%
Sell
44
Recursion Pharmaceuticals (RXRX) is a Sell

Is Recursion Pharmaceuticals a Buy, Sell or Hold?

  • The current Recursion Pharmaceuticals [RXRX] share price is $5.70. The Score for RXRX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RXRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
9
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $3.73. The Score for RVNC is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

RXRX Stock Price Chart

What is Recursion Pharmaceuticals's stock price today?

  • The Recursion Pharmaceuticals share price today is $5.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing slight selling pressure.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $3.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing selling pressure, which indicates risk of future bearish movement.

RXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 36.56 Sell
Chaikin Money Flow: -6628710 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.12 - 7.14) Sell
Bollinger Bands (100): (6.24 - 7.62) Sell

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 32.99 Sell
Chaikin Money Flow: -1111191 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.97 - 5.77) Sell
Bollinger Bands (100): (3.78 - 6.28) Sell

RXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.28 Sell
20-day SMA: 6.66 Sell
50-day SMA: 6.62 Sell
200-day SMA: 8.32 Sell
8-day EMA: 6.19 Sell
20-day EMA: 6.49 Sell
50-day EMA: 6.67 Sell
200-day EMA: 7.68 Sell

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.98 Sell
20-day SMA: 4.79 Sell
50-day SMA: 5.16 Sell
200-day SMA: 4.6 Sell
8-day EMA: 3.99 Sell
20-day EMA: 4.48 Sell
50-day EMA: 4.92 Sell
200-day EMA: 6.01 Sell

Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.

Recursion Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):